ArticleInternational journal of toxicology2023

Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib.

Lars van der Veen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.